$26.1 Billion is the total value of VIKING GLOBAL INVESTORS LP's 63 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -207,527 | -100.0% | -0.10% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -201,756 | -100.0% | -0.14% | – |
COO | Exit | COOPER COS INC | $0 | – | -273,563 | -100.0% | -0.18% | – |
COF | Exit | CAPITAL ONE FINL CORP | $0 | – | -1,162,593 | -100.0% | -0.39% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -1,395,107 | -100.0% | -0.43% | – |
BLL | Exit | BALL CORP | $0 | – | -1,832,789 | -100.0% | -0.49% | – |
NXPI | Exit | NXP SEMICONDUCTORS N V | $0 | – | -1,418,054 | -100.0% | -0.53% | – |
UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -1,220,743 | -100.0% | -0.66% | – |
CAR | Exit | AVIS BUDGET GROUP | $0 | – | -4,320,377 | -100.0% | -0.72% | – |
AON | Exit | AON PLC | $0 | – | -1,912,946 | -100.0% | -0.72% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -513,444 | -100.0% | -0.78% | – |
RCPT | Exit | RECEPTOS INC | $0 | – | -1,156,900 | -100.0% | -0.83% | – |
BIDU | Exit | BAIDU INCspon adr rep a | $0 | – | -1,285,451 | -100.0% | -0.97% | – |
FOXA | Exit | TWENTY FIRST CENTY FOX INCcl a | $0 | – | -8,093,383 | -100.0% | -1.00% | – |
CI | Exit | CIGNA CORPORATION | $0 | – | -2,914,815 | -100.0% | -1.78% | – |
MET | Exit | METLIFE INC | $0 | – | -11,780,357 | -100.0% | -2.49% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VISA INC | 36 | Q3 2023 | 7.0% |
AMAZON COM INC | 34 | Q3 2023 | 10.6% |
META PLATFORMS INC | 34 | Q3 2023 | 10.4% |
MICROSOFT CORP | 30 | Q3 2023 | 9.1% |
THERMO FISHER SCIENTIFIC INC | 29 | Q3 2023 | 5.4% |
NETFLIX INC | 26 | Q2 2023 | 6.0% |
MASTERCARD INCORPORATED | 25 | Q3 2023 | 3.9% |
ELEVANCE HEALTH INC | 24 | Q2 2023 | 10.2% |
ALPHABET INC | 22 | Q2 2021 | 9.3% |
UNITEDHEALTH GROUP INC | 22 | Q3 2023 | 5.3% |
View VIKING GLOBAL INVESTORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Celldex Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Coupa Software IncSold out | February 14, 2023 | 0 | 0.0% |
FIGS, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Guardant Health, Inc. | February 14, 2023 | 4,107,644 | 4.0% |
Orion Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
PROCEPT BioRobotics CorpSold out | February 14, 2023 | 0 | 0.0% |
Frazier Lifesciences Acquisition CorpSold out | November 25, 2022 | 0 | 0.0% |
Cazoo Group Ltd | November 10, 2022 | 60,000,000 | 7.3% |
AbCellera Biologics Inc.Sold out | February 14, 2022 | 0 | 0.0% |
Athira Pharma, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-03-20 |
SC 13G/A | 2024-03-20 |
4 | 2024-03-07 |
4 | 2024-03-07 |
4 | 2024-03-01 |
4 | 2024-03-01 |
SC 13G/A | 2024-03-01 |
4 | 2024-02-28 |
4 | 2024-02-28 |
SC 13G/A | 2024-02-28 |
View VIKING GLOBAL INVESTORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.